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ABSTRACT
The activation and maintenance of pulmonary viral disease is regulated at multiple levels and de-
termined by the early innate response to the pathogenic stimuli.  Subsequent activation events that
rely directly and indirectly on the virus itself can alter the development and severity of the ensuing
immunopathologic responses. In the present review we outline several interconnected mechanisms
that rely on the early recognition of viral nucleic acid for the most appropriate anti-viral immune
responses, including TLRs and Notch activation in DCs and T cells.  Deviation or persistence of the
immune response to respiratory viruses may impact significantly on the severity of the responses.
While these mechanisms are likely similar in most respiratory viral infections, this review will fo-
cus on findings with respiratory syncytial virus (RSV) infections.
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INTRODUCTION
THE INDUCTION OF IMMUNE RESPONSES IN THE HOST of-ten determines the nature and the severity of the en-
suing illness during infectious diseases. Studies have
shown that patients with severe respiratory viral infec-
tions have an increased risk for the development of
chronic pulmonary diseases (1–5). A number of respira-
tory viruses have been implicated in the induction of pul-
monary diseases, including infections with rhinovirus, in-
fluenza, parainfluenza, and adenovirus. Recent studies in
children (6) and adults (7) support this contention as it
relates to severe asthma exacerbations. Thus, viral infec-
tions not only can directly alter the health of an individ-
ual, but may also alter the immune environment within
infected tissues and thus allow progression of other
chronic responses. Several investigators have focused
upon respiratory disease using a model of respiratory syn-
cytial virus (RSV) infection, as this virus has epidemio-
logic links to the development of chronic airway disease.
Recent evidence suggests that RSV has a significant role
in elderly patient populations as well as in patients with
chronic obstructive pulmonary disease. Whereas RSV is
rarely fatal in infants, the impact of RSV on the elderly
has only recently begun to be recognized and may be as-
sociated with nearly as many deaths as influenza (8). The
specific mechanism(s) of immune regulation identified in
RSV studies may be relevant to other viral infections that
must be recognized and cleared properly or a more path-
ogenic disease progression could result. This review will
address the regulation of cellular immune responses dur-
ing viral infection that result in the activation of appro-
priate antiviral responses and focus on immune responses
in RSV infection models.
DENDRITIC CELLS AND RECOGNITION
OF INFECTIOUS AGENTS
In order to monitor pathogenic insults at mucosal sur-
faces a complex network of innate immune cells are po-
sitioned within the tissue with the ability to recognize
microorganisms. The surveillance function can be ac-
complished by resident macrophages that have the abil-
ity to quickly phagocytize bacteria and fungi for clear-
ance prior to colonization, thereby avoiding inappropriate
activation of the acquired immune system. The epithelial
cell barriers that have been set up also provide a reason-
able means of protecting the host from colonization, and
upon infection can initiate innate immune signals for the
recruitment of additional phagocytic cell populations.
However, in the case of viral infections, it is difficult, if
not entirely impossible, for the innate immune response
to clear the virus without activation of the acquired im-
mune system. Thus, the resident and recruited dendritic
cell (DC) becomes a critical link for recognition and
transport of the viral stimuli to the draining lymph node
for activation of the antiviral, cell-mediated responses.
The determining factor for the outcome of the response
depends upon how the DCs are activated and in what
manner the cells interact with the T cells. In addition, the
nature of the resulting acquired immune response likely
also depends upon the subsets of DC that are recruited,
activated, and participate in the initiation of the viral re-
sponses.
The ability to monitor the pulmonary environment for
pathogen infection is regulated at several levels. During
viral infections the innate immune response has adapted
mechanisms of pattern recognition to allow immediate
and effective identification of the invading microorgan-
isms. These include the toll-like receptor (TLR) activa-
tion pathways, both MyD88-dependent and independent,
as well as cytoplasmic triggers that include RIG-I and
PKR pathways (9–11). TLR4 was the first to be identi-
fied to have an effect in RSV infection via its interaction
with the F protein of RSV (12). While controversial
(13–15), a number of clinical studies have identified a
TLR4 polymorphism associated with susceptibility to se-
vere RSV infection (16–21). A recent study demonstrated
that the altered TLR4 protein can confer altered responses
in epithelial cells and peripheral blood mononuclear cells
(22). In our own studies comparing the response to RSV
infection in bone marrow–derived DCs from wild-type
versus TLR4-deficient DCs (C3H/HeJ), an early and sig-
nificant reduction in chemokine production with no al-
teration in IL-12 was observed (data not shown). Thus,
the role of TLR4 may depend upon the cell type and lo-
cation of the infection. Other TLR molecules that recog-
nize viral components are found in the endosomal com-
partment, where viruses uncoat and initially release their
nucleic acid prior to replication. Once the nucleic acid
begins to replicate in the cytoplasm, the relatively high
levels appear to activate cytoplasmic triggers such as
RIG-I, which drive strong type I IFN responses (23–25).
The expression of TLRs in DC subsets may be defining
for their function of monitoring the environment. While
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myeloid/conventional lineage DCs (cDCs) have a rela-
tively wide range of TLRs, including TLR2, TLR3,
TLR4, TLR5, and TLR6, the plasmacytoid DCs (pDCs)
primarily express TLR7 and TLR9. Because TLR7 and
TLR9 are primary recognition molecules for ssRNA and
unmethylated CpG sequences, the pDC likely plays a
prominent role in the initial phases of viral infection for
monitoring and eliciting the early responses. The notion
that pDCs may play an important role in regulation of
the immune response is logical given that the pDC is the
predominant producer of IFN-, a major innate cytokine
involved in antiviral immunity (26–28). This has been
supported in multiple studies that have demonstrated that
the removal of pDCs during viral infections leads to de-
creased viral clearance and increased immunopathology
(29–31). Critical experiments on pDC function initially
came after the development of antibodies that could
specifically deplete pDCs. Subsequently, the initial ex-
periments for pulmonary responses were performed by
depleting pDCs during allergic responses, and demon-
strated that in the absence of pDCs the allergic response
was greatly enhanced (32). The pDC subset was sug-
gested to have a suppressive response on T-cell activa-
tion. Recent studies, however, have indicated that pDCs
play multiple roles that include antiviral effects by di-
rectly limiting viral replication through the production of
type I IFN, as well as providing important immune reg-
ulatory functions by directing the phenotype of both the
CD4 helper T-cell responses and enhancing the CD8 cy-
totoxic T-cell responses. Thus, the activation of the once-
underestimated pDC has been demonstrated to have a
critical role in determining the direction of the immune
response, as well as the severity of virus-induced immune
responses. This latter concept was prominently identified
in a seminal study using herpes simplex virus infection
that demonstrated the necessity of pDC migration into
the lymph node for development of the most effective
CTL responses by affecting the nature of cDC activation
(31). This latter concept was recently supported in ex-
perimental RSV infection by depleting pDCs that led to
development of severe pathophysiology and altered im-
mune responses (29). Additional unpublished studies by
our laboratory using TLR7/ mice have indicated that
TLR7 and pDCs are the primary source of IFN-. The
lack of signaling through this pathway alters the immune
response to RSV infection (data not shown) in a similar
manner as that described with MyD88/ animals (33),
leading to increased pathogenesis. Together, these stud-
ies begin to describe a system in which the pDC subset
participates in the overall antiviral immune response in
a coordinated effort with the cDC subset.
Myeloid DCs also play a central role in antiviral im-
munity and have been subdivided in several ways. Most
recently the function of this subset may be best defined
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based on the co-stimulatory molecule display and the cy-
tokine production profile. Subsets of cDCs that express
high levels of CD40 and CD80, and produce high levels
of IL-12 are more efficient for promoting a Th-1 type re-
sponse, whereas those that express OX40L and lower lev-
els of IL-12 promote a predominantly Th-2 response
(24,34–36). The activation of cDCs through specific TLR
molecules induces important instructive signals ex-
pressed during viral infection, including co-stimulatory
molecules (CD40 and CD80) and cytokine responses 
(IL-12 and type I IFN). Together these signals promote
a Th-1-type response. While numerous signals that
prompt cDCs to become “Th-2 cell inducers” have been
suggested, one airway epithelial cell–derived molecule,
TSLP, has aroused the interest of researchers (37,38).
TSLP directly activates DCs and promotes Th-2 re-
sponses through the expression of OX40, as opposed to
other critical co-stimulatory molecules (39). In addition,
TSLP promotes the production of CCL17 and CCL22,
which preferentially bind to CCR4, a chemokine recep-
tor found at high levels on Th-2 cells (40,41). Thus, the
determination of whether cDCs will promote a Th-1- or
Th-2-mediated response may be dependent upon the na-
ture of the signal that it receives from the pulmonary en-
vironment. In addition, specific signals, such as TSLP
versus IFN-, may determine the nature of the immune
response, and depend entirely upon the cell population
(epithelial cell versus pDC) that supplies the virus-in-
duced cytokines for maturation of the cDC prior to in-
teraction with the T cell. Activation within the lymph
node in the presence of properly activated pDCs have
also been shown to be critical for an appropriate immune
response via subsequent cDC activation (31).
A complex relationship is beginning to develop be-
tween the different DC subsets and the regulation of im-
mune responses within the lung that may depend upon
how these different APC populations are initially acti-
vated. Why is it that RSV drives such a profound and un-
desirable response compared to other respiratory viruses?
This information may be gleaned from the mechanism of
how RSV infects cells compared to the other respiratory
viruses. The mode of infection of RSV appears to be
through either membrane fusion and subsequent release
of ssRNA into the cytoplasmic compartment, or through
clathrin-mediated endocytosis that was pH-independent,
as opposed to entry into the cell via a receptor-mediated
endosomic compartment through specific receptors that
are pH-dependent (42,43). The ability of RSV to enter
the cell directly into the cytoplasm is likely the reason
that RIG-I is the primary activation pathway, whereas
TLR-induced type I IFN is not produced until later time
points of infection, when pH-dependent endosomic
events occur (44). Once RSV begins to expand its RNA
its components may depend upon autophagy-associated
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and other mechanisms to activate a number of innate im-
mune pathways that depend upon endosomic entry for
the TLR-induced activation events discussed above (45).
While the literature at present is not entirely clear in this
area, the delay in TLR-mediated activation prior to trans-
port to the endosome may give RSV an advantage due
to a delay in TLR-induced mediator production. In fact,
a recent study demonstrated that pDCs depend upon au-
tophagy for IFN- production during viral infections,
such as that with VSV, that enter the cell via a cytoplas-
mic route, whereas those that enter via the endoplasmic
compartment do not depend upon autophagy (46). Au-
tophagy pathways may provide a logical way to activate
the acquired immune system to facilitate viral clearance,
but could also provide a process for dysregulation dur-
ing chronic or severe disease (47). A better understand-
ing of these activation events may allow additional av-
enues of therapeutic control during complex disease
phenotypes within the lung immune environment, as well
as provide additional information that may allow better
vaccine design.
ADAPTIVE IMMUNE RESPONSES TO
RESPIRATORY SYNCYTIAL VIRUS
The innate immune response is initiated to quickly pro-
tect the host from overwhelming infectious organisms,
but can also tailor the adaptive immune response to the
invading pathogens. During respiratory viral infections
the balance of CD4 and CD8 responses manages the pro-
gression of the response. It is now clear that RSV-spe-
cific T cells are both protective and pathogenic. In mice
depleted of CD4 and CD8 T cells, RSV persists for sev-
eral weeks but no overt disease symptoms are observed
(48). Individually, both CD4 and CD8 contribute to ter-
minating RSV replication, but often at the cost of sig-
nificant immunopathology. Some groups have investi-
gated the immune response directed toward specific viral
proteins. In studies in which mice were vaccinated with
vaccinia vectors containing F, G, N, or M2 protein, Th-
2-mediated disease only resulted upon challenge in mice
primed with the G protein (48–52). Studies demonstrated
that while the F protein primed for both CD4 and CD8
responses, the G protein only generated CD4 memory re-
sponses. The defective response that resulted in Th-2-me-
diated disease and eosinophilia could be alleviated by
vaccinating mice with a G-protein vaccinia vector that
also contained an RSV-specific CD8 epitope. These lat-
ter observations may help explain the disastrous vaccina-
tion strategy using formalin-fixed RSV that elicits a strong
Th-2-mediated disease in vaccinated and infected infants
(53). Nearly all vaccination strategies against RSV using
killed or fixed virus led to inefficient antiviral immune re-
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sponses and increased immunopathology, and have led re-
searchers to begin examining attenuated live vaccine
strains (54,55). Thus, the instructive signals used by DCs
to activate T cells may depend upon live virus to initiate
the most appropriate and least pathogenic responses.
While CD8 T cells play a role in viral clearance, pre-
vious studies indicate that RSV may impair CD8 T cells
that are recruited to the lung. Using MHC class I tetramer
staining, lung CD8 T-cell expansion was shown to occur
in response to primary RSV infection (56,57). However,
when these RSV-specific CD8 T cells were isolated from
the lung, they were impaired in their ability to secrete
IFN- and upregulate perforin. Interestingly, depletion of
CD8 T cells have led to enhanced Th-2 responses dur-
ing RSV infection, demonstrating that CD8 T cells may
provide important regulatory signals, such as IFN- (58),
suggesting that they may not be defective in all cases. In
response to RSV, DCs upregulate co-stimulatory mole-
cules, but may also provide specific factors that regulate
the acquired responses. While the mechanisms involved
in suppressing the functions of CD8 cells by RSV are un-
known and still controversial, these mechanisms may al-
low for recurrent or persistent infections. In other stud-
ies, it has also been shown that DCs co-cultured with
RSV have a suppressive effect on IFN- production by
CD4 T cells in vitro (59). Thus, a multitude of im-
munoregulatory responses may stem from inappropriate
DC activation.
A number of studies have identified that many of the
pathophysiologic changes during RSV infection using ex-
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perimental models relate to the cytokine phenotype that
is generated. In particular, the induction of IL-13 appears
to be closely associated with several aspects, including
airway hyperreactivity, mucus hypersecretion, and ex-
cessive inflammation (60–62). Additional studies in hu-
mans have linked specific IL-13 as well as IL-4 haplo-
types with a preponderance to develop airways disease
(63–65). Thus, the distinct activation signals that drive
these responses may be governed genetically and not be
controlled by the viral infection alone, leaving distinct
subsets of patients at substantial risk. In contrast, the gen-
eration of the Th-1 cytotoxic response generally relies on
the production of factors such as IL-12 and IFN-/ from
TLR-mediated activation pathways. Pathogen-induced
Th-2 responses may preferentially arise in the absence of
strong TLR-induced responses that are characterized by
low IL-12 levels. Interestingly, studies using cord and
peripheral blood from infants that develop severe RSV
infections had significantly lower levels of IL-12 pro-
duction compared to responses in children with mild 
RSV disease (66,67). This idea is supported by studies
that show that MyD88/ mice, which cannot generate 
IL-12 in response to viral infection, are incapable of gen-
erating Th-1 responses when immunized with complete
Freund’s adjuvant and ovalbumin (68). RSV infection in
MyD88/ mice generated a predominant Th-2 response
with an accompanying increase in pathogenesis that in-
cluded eosinophilia and mucus hypersecretion (33).
While many of the responses observed during severe
RSV infections in patients can be attributed to activation
by Th-2 cytokines, such as eosinophilia and mucus over-
production, others are associated with acute or Th-1-type
responses, such as neutrophilia, fever, and weight loss. It
is likely that the most severe and prolonged disease phe-
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FIG. 1. Peripheral blood mononuclear cells were isolated
and CD14 myeloid cells were purified and incubated for 6 d
with GM-CSF and IL-4 to induce mDC differentiation. pDCs
were isolated directly from the mononuclear cell population.
Cells were infected with RSV (moi  1.0) and mRNA isolated
at 12 h post-challenge.
FIG. 2. The activation of the appropriate CD4 T-cell re-
sponses is most appropriately induced by the interaction with
both pDC and mDC subsets that each supply important signals
for T-cell differentiation.
notypes are a combination of a complex interaction of
both cytokine phenotypes, and both must be considered.
An alternative explanation is that specific pathogens
stimulate Th-2 responses through DC receptors and sig-
nals that are not fully defined, and it is not merely the
absence of Th-1-inducing instructive signals. Recent ev-
idence for this latter possibility comes from studies indi-
cating that expression of the Notch ligands Delta-like and
Jagged can provide instructional signals for the develop-
ment of Th-1 and Th-2 cells, respectively (69).
THE ROLE OF NOTCH AND NOTCH
LIGANDS FOR REGULATION 
OF VIRAL RESPONSES
Notch family molecules provide an activation network
that has been traditionally associated with development,
but has also become well known for regulating complex
immune responses (69–71). There are four mammalian
Notch receptors (Notch1 though Notch 4) with activation
pathways that are not fully understood (70,72,73). A key
molecule, MAML, is required to recruit co-activators for
transcriptional activation by Notch (74–76). In recent
years Notch has been shown to be involved in T-cell lin-
eage maturation in the thymus, allowing double negative
pro-T cells to mature into double positive CD4/CD8 T
cells (77–79). In the mature immune system the Notch
pathway has been described as a signaling mechanism in-
volved in regulating cell lineage choices for CD4 T
cells. Upregulation of the Delta-like Notch ligands in DCs
polarized Th-1 cells, whereas the Notch ligand Jagged
induced Th-2 cell polarization (80). Studies have sepa-
rately demonstrated that Notch activation can be utilized
for the generation of Th-1, Th-2, or Treg cell generation,
but depends upon additional signals (80–84). Recent
studies using genetically altered animals have indicated
that Th-2 immune responses are fully dependent upon
Notch activation, while Th-1 responses can develop in
the absence of Notch signaling (85,86). In recent studies
in our lab we have concentrated on Delta-like 4, which
is the primary Notch ligand that is upregulated by RSV
infection of DCs (87). When specifically blocking Delta-
like 4 in vivo by passive immunization during RSV in-
fection, a more intense pathogenic response including
increases in airway hyperreactivity and mucus hyper-
secretion was observed. The response was characterized
by elevated Th-2 cytokine production that could be re-
versed in vitro by culturing T cells with rdll4 in re-stim-
ulation studies. Altogether, it appears that the role of
notch ligand expression by DCs can differentially regu-
late the outcome of a viral immune response.
More recently we have also characterized whether
there was differential expression of notch ligands by sub-
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sets of DCs. In particular, we have continued to focus on
differences between the expression in cDCs versus pDC
subsets after RSV infection, as studies have suggested
that different DC subsets may differentially express notch
ligands (88). Our recent data indicate that when we ex-
amine these two DC subsets from human peripheral blood
(Fig. 1), we observe that pDCs but not cDCs express a
high level of dll4 after RSV infection. Furthermore, when
we examine a number of other innate mediators, we find
that the pDCs predictably express much higher levels of
IFN-/, while the cDCs express significantly more 
IL-10 and IL-12. Thus, these DC subsets may provide
distinct but equally important instructive signals to help
differentiate the T-cell-mediated immune responses.
SUMMARY
Determining how the different subsets of DCs work
together to promote the most efficient antiviral response
with minimal pathogenesis by driving a Th-1 versus Th-
2 cytokine profile (Fig. 2) will be an onerous task for re-
searchers. The generation of the most effective antiviral
responses requires multiple directional signals. Without
these interacting cues the immune response would be al-
tered and potentially lead to long-term sequelae and per-
sistent pathogenic pulmonary disease. While the rele-
vance of DC, TLRs, and Notch in the activation of the
mature immune system is a story that is only beginning,
it provides an important concept of how the maturing im-
mune system relies on a diverse set of molecules and cell
populations to fine-tune the system for the most appro-
priate and least pathogenic responses. A better under-
standing of these and other signals not only will aid in
detecting potential patient populations that are at risk, but
may offer additional avenues for more informed vaccine
strategies.
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